Investors' Chronicle
Investors' Chronicle
0
Investors' Chronicle is a podcast that explores key trends in the financial markets and offers insights for private investors. It features exclusive interviews with professional investors, fund managers, and financial experts. The show aims to help listeners make smarter investment decisions by highlighting rewarding opportunities. With over 160 years of history, Investors' Chronicle is a trusted source for investment research and analysis in the UK.
Епизоди
-
Back to basics: How to build a portfolio 15.09.2026 28минFiguring out which funds to buy is overwhelming for even the most experienced investors – but as a beginner, it’s important to understand your options so you can make the right decisions. Funds editor Val Cipriani is in the studio with personal finance editor Holly McKechnie to break down the process. First, the duo explains what a fund is, the three main types, and why they are a good option to kick-start your investment journey. Val then dives into the difference between stocks and bonds, while also helping you to understand risk tolerance and how to figure out what kind of investor you are or want to be.Before rounding off, Val gets into the nitty-gritty of portfolio-building best practices. From keeping it manageable to controlling your costs, Val and Holly have you covered. If you want to get started, you can check out our Top 50 funds here.Timestamps00:00 Intro00:45 Why a fund is a good option for beginner investors04:32 The different types of funds13:30 How to build a portfolio and decide your asset allocation17:36 Understanding active fundsListen to episodes of Women & Wealth by clicking here or on ACast, Apple, Spotify or YouTube.If you have any questions you’d like the duo to answer, email [email protected] or [email protected]' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
Semiconductor stocks, our Top 50 Funds and Mortgage Advice Bureau: Companies and Markets Show 11.09.2026 37минEven as uncertainty reins in the markets, 2026 has been another bumper year for returns. But, as ever, that does hide plenty of dispersion below the surface; with that in mind, this week’s show looks at two stocks at opposite ends of the scale.One is up over 800 per cent in the year to date – that’s semiconductor manufacturer IQE, which reported interim results on Monday. Michael Fahy is in the studio to dive into the details and ask whether its run can continue.At the other end of the spectrum is Mortgage Advice Bureau, which fell 20 per cent on Wednesday after lowering full-year guidance. Julian Hofmann asks whether there’s any light at the end of the tunnel after it departed from Aim, and will also run the rule over the thus-far better-performing Property Franchise Group.In between, we turn to our Top 50 Funds of 2026. Val Cipriani and her expert panel have compiled our annual rundown of 50 active funds we think may be suitable for a range of investors. Val talks through our picks.Timestamps: 00:00 Intro01.14 IQE14:19 Top 50 Funds26:17 Mortgage Advice BureauListen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
Our favourite ETFs, toxic stocks to avoid and industrials: Companies and Markets show 04.09.2026 38минThis week’s show begins with a look at Meta after the social media giant had to fork out $18bn following accusations that its products are deliberately addictive for younger people. Valeria Martinez is in the studio to discuss whether big tech and other sectors are now the new ‘sin stocks’ and whether the companies which are so irresistible to consumers are toxic for investors. We then discuss our annual Top 50 ETFs best-buy list, released earlier this summer. Val Cipriani talks us through how it was compiled, some of the changes, and what investors should consider when buying tracker funds.Finally, we look at building materials supplier Grafton, which released half-year results on Thursday morning. Mark Robinson weighs up whether its UK struggles are being offset by better business in the rest of Europe and its home market of Ireland, and what this means for the investment case.Timestamps:00:00 Intro01:09 Top 50 ETFs12:34 A new age of 'Sin stocks'27:10 Grafton's resultsListen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
Protecting your pension, UK industrials and Nvidia: Companies and Markets Show 28.08.2026 28минFirst, we cast our ears to British industrial stocks and ask whether they are being picked off too cheaply. Michael Fahy dives into why manufacturers are significantly more undervalued than their US counterparts and discusses the sector’s acquisitions in recent years.We then turn to what is arguably our most important savings pot: the pension. You may have saved diligently and kept a close eye on your investments, but unexpected problems can still arise. From a later-life divorce or a stock market slump, plenty can throw retirement into jeopardy. But fret not, Holly McKechnie is in the studio to talk through the most common threats – and how to avoid them. Finally, we look at Nvidia and its keenly anticipated earnings update. To investors’ joy, it delivered on all fronts and revenue at the world’s largest company more than doubled, smashing Wall Street’s expectations. Arthur Sants explains the latest figures and its new circular financing strategy, which is raising a lot of eyebrows (more on that here).Timestamps00:00 Intro03:32 Are UK industrials being picked off too cheaply?19:95 Common risks to your pension – and how to avoid them20:36 Nvidia's promising figures and new financing strategyListen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
How to invest under Andy Burnham: Lee and the IC 25.08.2026 44минAfter a summer hiatus, Alex Newman and Lord Lee are back in the studio, and the duo have a lot to catch up on. The UK has seen a change of prime minister, record-breaking heat and plenty of action in stock markets.First, the pair turn to Britain’s new government. While Andy Burnham and John Healey have revealed very little about their fiscal plans, Lord Lee gives his thoughts, including how to encourage the country’s sleepy retail investor base. The episode then moves to listener questions, John’s approach to stockpicking and the latest buys, sells and changes in his own portfolio. Highlights include Primary Health Properties’ lofty yield and why he believes investing is an “art rather than a science”.Timestamps00:00 Intro01:08 Lord Lee's thoughts on Burnham's Britain10:18 A look into John's portfolio: Buys and sells21:09 Jet2, PZ Cussons, Christie Group and more33:26 Goodwin, income stocks and takeover opportunitiesLet us know your thoughts, or if you have any questions or any suggestions for future guests, by emailing [email protected] to more podcasts from Investors’ Chronicle by clicking here or heading to Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
JD Sports, Pershing Square’s overhaul and Oxford Nanopore:Companies and Markets Show 21.08.2026 28минUp first this week is self-labelled ‘King of Trainers’ JD Sports, whose shares took a 15 per cent tumble on Thursday morning. The FTSE 100 retailer has blamed much of the slump on delayed back-to-school spending and a rising cost of living. Erin Withey explains what’s going on.Next we turn to what has become a trend of the past few months: star fund managers overhauling portfolios. Bill Ackman of Pershing Square has joined the party in trying to stop disappointing returns, but when your portfolio only has around 12 stocks, and you change 11 of them, it’s going to have some significant repercussions. Val Cipriani is in the studio to discuss whether the shake-up is for the better or whether investors should be worried. Finally, we look at Oxford Nanopore; initial excitement after its IPO has waned, and the testing company has struggled as its biggest segment, its research arm, has lagged. Julian Hofmann dives into its management’s plans to switch up its strategy and what this means for shareholders.Timestamps: 00:00 Intro3:59 JD Sports10:57 Pershing Square20:08 Oxford NanoporeListen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
Legal & General, infrastructure stocks and GSK: Companies and Markets Show 14.08.2026 26минAfter an avalanche of earnings updates, we turn to our annual Income Majors special report and dive into two prominent FTSE 100 dividend stocks. First up is insurer Legal & General; pressure has been mounting on the company as it grapples with a more competitive pensions market. Christopher Akers explains the CEO’s buyback plan, its yield and what it means for investors.We then move to GSK, once known as GlaxoSmithKline, which faces a tricky balancing act between dividends and developing new drugs. The pharma giant has been spending heavily on R&D – a staggering £18bn this year alone to build its oncology pipeline. Julian Hofmann has the details.Finally, we cast our ears to Hill & Smith’s growth across the pond. The steel products company now generates two-thirds of its revenue from the US and has even switched its currency from sterling to dollars. Michael Fahy discusses what’s going on at the growing business.Timestamps: 00:00 Intro03:22 Legal & General10:42 GSK18:57 Hill & Smith Listen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
How to defeat the gender wealth gap 11.08.2026 27минWomen, on average, earn less than men, have less saved in a pension and have to take more time off from work to care for others. But while society is rigged to burden women with heavier loads, Gina Miller has made it her mission to change this and close the gender wealth gap. Gina is an activist, entrepreneur and the founder of MoneyShe, an investment platform focused on women’s finances. Gina, who became widely known for her anti-Brexit campaign and has spent decades working in the City, sits down with funds editor Val Cipriani to discuss the barriers blocking women from investing, the inherent misogyny in finance and practical steps to build a portfolio.She also discusses the financial consequences of having cancer and her experience with economic abuse.Timestamps00:00 Introduction02:41 Understanding the gender wealth gap06:09 Why women invest less than men10:41 Practical tips for getting started15:12 Misogyny in finance and campaigning for change20:02 The financial impact of cancer23:12 Economic abuse and financial independence26:24 MoneyShe and Gina’s current campaigning workWomen and Wealth is the monthly podcast series from Investors’ Chronicle. You can listen to and watch the episodes alongside our other podcasts on Acast, Apple, Spotify or YouTube.If you have any questions you’d like Val to answer in the podcast, email [email protected]' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
The AI jobs crunch, medical stocks and AstraZeneca: Companies and Markets Show 07.08.2026 37минM&A activity remains rampant, and this week we start with a tie-up that would rank among the biggest deals of all time: AstraZeneca and US rival Bristol Myers Squibb. Julian Hofmann discusses the merits of the mooted $400bn deal, the drawbacks and why investors’ response to the rumour has been bleak. We then turn to what could be the greatest disrupter humans have seen for decades: the rise of AI and what it means for the jobs market. As speculation runs rampant as to how many roles could be lost, Hugh Moorhead is in the studio to curb some of those concerns. Hugh explains what’s actually going on, which companies might stand to benefit, which might not, and how investors should respond.Finally, Mark Robinson puts medical device maker Smith & Nephew under the microscope after its half-year figures suggest its long-awaited rebound hasn’t quite arrived. But with an activist lurking on the shareholder register, could better times be on the way?Timestamps00:00 Introduction1:20 AstraZeneca15:43 AI's impact on the jobs market and what this means for investors30:23 Smith & NephewListen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
US IPOs, Rentokil and emerging markets: Companies and Markets show 31.07.2026 29минResults season is in full swing, and it’s been another bumper week – with the overwhelming majority positive. But there are always laggards, and this week’s show dives into one of the FTSE 100’s biggest fallers, Rentokil. The pest control business’s shares plunged after its half-year figures. Julian Hofmann explains why.Then, we look overseas, with many of the big AI and semiconductor trades going into reverse over recent weeks, including memory-chip makers SK Hynix and Samsung. So what better time to discuss how to pick out the value shares in these global markets. Michael Fahy talks through his favourites. And finally, we look at the consequences of the SpaceX IPO for Britain’s investors – not the losses on which they’re sitting, but the possibility of it having tipped the first domino on access to US IPOs. Helen Kirrane explains what’s going onTimestamps00:00 Introduction00:57 Rentokil10:54 Global value hunting22:33 US IPOsListen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
‘We are the space 3i’: Mark Boggett of Seraphim Space 28.07.2026 43минSeraphim Space (SSIT) has been one of the best performing investment trusts in the past year. Helped by the enthusiasm for the sector generated by SpaceX, the £400mn trust pulled off a rare fundraising and now has a pile of cash to deploy.Val Cipriani sits down with chief executive Mark Boggett, who discusses opportunities and volatility in space, why he isn’t afraid of concentration, and how space technology could prove as revolutionary as the internet or AI.You can listen to the interview, alongside all of our other podcasts, on Acast, Apple, Spotify or YouTube.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
Terry Smith, construction stocks and Mony Group:Companies and Markets Show 24.07.2026 40минAs the half-year results season falls upon us, a smorgasbord of companies are reporting over the next few weeks. But today’s episode focuses on two whose outlooks are already in.Hugh Moorhead looks at contractor Morgan Sindall, which reported ahead of this episode’s recording on Thursday. This is followed by Mark Robinson, who talks through comparison website Mony, better known as MoneySuperMarket. Hugh discusses Sindall’s merits, while Mark weighs up Mony’s valuation. But before diving into results, we must cast our ears to what is arguably the biggest funds story of 2026. Terry Smith, of Fundsmith, decided to abandon his longstanding ‘do nothing’ approach in favour of a momentum strategy, overhauling more than half his portfolio in six months. Funds editor Val Cipriani unpacks what’s going on and explores whether or not investors should throw in the towel.Timestamps00:00 Intro01:50 Terry Smith20:12 Morgan Sindall31:50 Mony GroupListen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
AI inflation, defence stocks and India funds: Companies and Markets Show 17.07.2026 28минThis week begins with how booming demand for AI infrastructure is driving a sharp increase in the price of memory chips. Erin Withey is in the studio to explain what this means for supply chains, which companies are winning as a result, and whether the squeeze is here to stay. Casting our ears abroad, we move to India, where a recent rally in the country’s equity funds has sparked investor interest. Helen Kirrane unpacks the reasons why lower oil prices and attractive valuations are boosting sentiment, and which funds are at the forefront of the recovery. More updates on that hereFinally, Michael Fahy talks through defence contractor Cohort, after it reported another year of strong growth. Mike discusses how a rising demand for its electronic warfare systems is fuelling its healthy order book and filling its pockets.Timestamps:00:00 Intro03:42 AI inflation11:58 India funds17:24 Cohort resultsListen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
Labour’s social media plans, house prices and legal stocks: Companies and Markets Show 10.07.2026 26минThis week’s show begins with Labour’s decision to force tech giants to give more prominence to traditional news broadcasters on social media, to help battle misinformation. Valeria Martinez discusses what this quick-fire solution to get younger people to engage with older news outlets means for investors and the companies involved.We then turn to Britain’s housing market as the cost of homes crept up in June. Hugh Moorhead dives into whether it’s showing signs of meaningful recovery, regional trends and how affordability pressures are affecting buyers. Hugh also talks through housebuilder Vistry’s dramatic share price plunge this week.Finally, Julian Hofmann discusses the success of legal firm Knights after it released positive results this week. With its acquisition-led strategy proving fruitful and cash generation benefiting shareholders, Julian explores how it’s growing without resorting to borrowing.Time stamps: 00:00 Introduction03:39 Broadcasters13:18 Outlook for Britain's housing market19:34 Knights results Listen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
What is the gender health gap – and how to beat it 07.07.2026 24минThe gender health gap is an issue which affects far more than just wellbeing; it impacts your career, earnings and long-term financial stability.In this episode of Women and Wealth, funds editor Val Cipriani and personal finance editor Holly McKechnie walk you through why women experience poorer health than men, how it is a systemic issue of under-investment in women’s healthcare and what this means for your finances. The duo explore how the menopause and conditions such as endometriosis affect your earnings and pension pot. Holly and Val also explain how employers can improve support and offer practical steps women can take to protect their pockets from sudden or long-term illness.Women and Wealth is the monthly podcast series from Investors’ Chronicle. You can listen to and watch the episodes alongside our other podcasts on Acast, Apple, Spotify or YouTube.If you have any questions you’d like Val and Holly to answer, email [email protected] 00:00 Introduction 01.19 What the gender health gap is and how it impacts your finances11.46 Impact of menopause and endometriosis on a your working life15: 51 Practical things to improve your financial security24:13 OutroInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
AI vs recruiters, another IPO and farming stocks 03.07.2026 35минIn this week’s episode, we turn to Britain’s recruitment stocks. Valeria Martinez looks at the impact of AI on hiring demand, which is hitting share prices, and also discusses the perennial question: is the new technology a concern or an opportunity?Next, we cast our ears to Italian tech buyout specialist, and Baillie Gifford favourite, Bending Spoons, following its Nasdaq debut earlier this week. Val Cipriani dives into its growth strategy and what the IPO means for investors and the likes of Scottish Mortgage.Lastly, Julian Hofmann looks at agricultural supplier Wynnstay (WYN), after it announced positive results despite headwinds for the farming sector. Julian explores how the company is navigating volatile fertiliser prices, cutting costs, and the reasons to be optimistic.Timestamps00:00 Introduction04:20 AI vs the recruitment sector15:12 Bending Spoons25:03 Wynnstay resultsListen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
Ocado, asset managers and Telecom Plus: Companies and Markets Show 26.06.2026 29минThis week, we begin with online grocer Ocado (OCDO) following reports of a CEO switch. Julian Hofmann dives into what a potential change at the top will mean for the FTSE 250 company that has struggled to deliver despite decades of investing in its technology. Next, we turn to Liontrust Asset Management (LIO), where, despite another year of poor results, it reported an early completion for its acquisition of River Global. Christopher Akers explores the positive response to the news and whether M&A offers a road to recovery.Lastly, we look at Telecom Plus (TEP), better known as Utilities Warehouse, after it slashed dividend payouts and cut forecasts. Julian is back to discuss the provider’s plans to kick-start customer growth and considers whether investors are right to have confidence in the turnaround. Timestamps00:00 Intro06:33 Ocado12:17 Liontrust Asset Management20:08 Telecom PlusListen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
AO World, wealth managers & Castings: Companies and Markets Show 19.06.2026 31минThis week, we begin proceedings with a look at the contrasting fortunes of two UK wealth managers: Aim-traded Tatton Asset Management (TAM) continues to reap rewards from its dominance of the model portfolio market. But its older rival, Rathbones (RAT), ran into trouble this week when it announced it would temporarily stop accepting investments from some higher-risk clients following a review by the regulator. Chris Akers is with us to shed some light on both situations.After that we look at online retailer AO World (AO.), which continues to make a better fist than it once did of operating in an environment of shaky consumer confidence. Erin Withey will talk about the company’s growth strategy and its plans to return money to shareholders.Lastly we turn to Castings (CGS), the 190-year old foundry operator that sells into the HGV market. Mark Robinson is here to analyse its recent results and to consider whether this is a turnaround situation.Timestamps00:00 Intro01:03 Wealth Managers09:47 AO World20:22 CastingsListen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
Meeting with Fevara’s CEO: Lee and the IC 16.06.2026 44минFevara (FVA:127p) may be new in name, but its roots and expertise stretch back more than a century through the former Carr’s Group. In the wake of this major transformation, the livestock supplements company’s focus is now on improving farming productivity through its advanced animal feed technology and supplements, and overseas expansion.Alongside chief executive Joshua Hoopes, Alex Newman and Lord Lee delve into the company’s strategy both at home and in South America. They cover Fevara’s lofty ambitions in Brazil – its acquisitions so far, the competitive advantages of the country, and the company’s targets for long-term growth. They also discuss why Hoopes believes Fevara can continue growing despite structural changes across the agricultural sector, and issues concerning sustainability and the climate crisis.The trio also explore shareholder returns, dividend policy and the outlook for global cattle markets.Let us know your thoughts, or if you have any questions or any suggestions for future guests, by emailing [email protected]:00 Intro02:48 Fevara’s transformation07:00 Fevara’s feed supplements17:18 Why Brazil is Fevara’s biggest growth opportunity27:39 Sustainability, emissions and the future of cattle farming38:04 Lord Lee’s latest portfolio movesListen to more podcasts from Investors’ Chronicle by clicking here or heading to Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information. -
Investing in photonics, GSK and new opportunities in venture capital: Companies and Markets Show 12.06.2026 33минThis week’s show dives straight into safety and equipment maker Halma (HLMA), which reported its full-year results on Thursday morning. It may be time to re-evaluate the company’s description as one of the FTSE 100’s least newsworthy businesses – it has been reaping the rewards of the AI boom. But with increased interest comes heightened expectations, and perhaps this is why its shares tumbled by 15 per cent on the day of the results. Mark Robinson digs into the details on whether this ‘quality stock’ is more volatile than it once was.We then turn to big pharma giant GSK (GSK). The drugmaker made its largest deal in over a decade earlier this week with the acquisition of US cancer biotech Nuvalent. Julian Hofmann takes a look at the $11bn deal and what it means for the future of the pharmaceutical company.Finally we discuss venture capital trust Molten Ventures (GROW), whose investments in the likes of fintech Revolut and microsatellite operator ICEYE have helped boost its returns. Mark is back to explore its portfolio and looks at whether the trust is morphing into something different.Timestamps00:00 Introduction01:22 Halma14:47 GSK23:06 Molten Ventures32:25 OutroListen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Популярен в
Този подкаст се появява и в подкаст класациите на тези държави.